ID
38308
Beschrijving
Study ID: 109035 Clinical Study ID: 109035 Study Title: A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of GSK163090 in Subjects With Major Depressive Disorder Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00896363 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GSK163090 1 mg, GSK163090 Placebo, GSK163090 3 mg Trade Name: Study Indication: Depressive Disorder
Trefwoorden
Versies (2)
- 09-10-19 09-10-19 -
- 24-10-19 24-10-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
9 oktober 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Efficacy and Safety of GSK163090 in Subjects with Major Depressive Disorder; NCT00896363
Common CRF : Other Previous Treatment for Migraine
- StudyEvent: ODM
Beschrijving
Other Previous Treatment for Migraine
Alias
- UMLS CUI-1
- C0149931
- UMLS CUI-2
- C1514463
- UMLS CUI-3
- C0205394
Beschrijving
Migraine Disorders, Prior Therapy, Other
Datatype
text
Alias
- UMLS CUI [1,1]
- C0149931
- UMLS CUI [1,2]
- C1514463
- UMLS CUI [1,3]
- C0205394
Beschrijving
Migraine Disorders, Prior Therapy
Datatype
text
Alias
- UMLS CUI [1,1]
- C0149931
- UMLS CUI [1,2]
- C1514463
Similar models
Common CRF : Other Previous Treatment for Migraine
- StudyEvent: ODM
C1300638 (UMLS CUI [1,2])
C1514463 (UMLS CUI-2)
C0205394 (UMLS CUI-3)
C1514463 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C1514463 (UMLS CUI [1,2])